Bayer
Bayer AG is a multinational life sciences enterprise with core business competencies focused heavily in the fields of human healthcare and agricultural innovation. The company operates through three primary operating segments consisting of Pharmaceuticals, Consumer Health, and Crop Science. Its principal revenue drivers are the global commercial sales of prescription pharmaceutical medicines, consumer health products, advanced seeds, and agricultural chemical crop protection solutions. The firm serves medical professionals, healthcare providers, retail patients, agricultural producers, and distribution partners across a vast network of international markets. Bayer holds a leading position globally within the life sciences sector, successfully combining advanced pharmaceutical research with large-scale agricultural input production. The company is headquartered in Leverkusen, Germany, and its shares are publicly listed on the Frankfurt Stock Exchange.
55 of the funds FundTelligence covers report a position in Bayer.
- Legal name
- BAYER AG
- Sector
- Health Care
- Country
- Germany
- Funds holding it
- 55
- Exposure themes
- Reproductive health, Treatment, Women's Health
Funds holding Bayer
- FAST Global Fund — Fidelity · 5.8 % (largest positions only, October 2026)
- Fidelity Germany Fund — Fidelity · 5.3 % (largest positions only, October 2026)
- DWS Invest CROCI Euro — DWS · 4.2 % (full portfolio disclosed, June 2026)
- DWS Invest German Equities — DWS · 3.26 % (full portfolio disclosed, June 2026)
- BlackRock iShares MSCI Europe Health Care Sector UCITS ETF — BlackRock · 3.09 % (full portfolio disclosed, October 2026)
- Fidelity Global Healthcare Fund — Fidelity · 2.9 % (largest positions only, October 2026)
- Handelsbanken Europa — Handelsbanken · 1.93 % (full portfolio disclosed, October 2026)
- Schroder ISF Healthcare Innovation — Schroders · 1.64 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 55 funds holding it.